Sign In
Buy PCRX
$22.32
+0.0700 (+0.315%)
At Close: Jun 03, 2026
Guggenheim Initiates Coverage On Pacira BioSciences with Neutral Rating
10:16am, Wednesday, 27'th May 2020Hancock Whitney Corp Invests $324,000 in Pacira Biosciences Inc (NASDAQ:PCRX)
07:54am, Wednesday, 27'th May 2020
Hancock Whitney Corp acquired a new position in shares of Pacira Biosciences Inc (NASDAQ:PCRX) in the first quarter, HoldingsChannel.com reports. The institutional investor acquired 9,649 shares of th
May 25, 2020 (Market Insight Reports) --
The MRI Safe Biopsy Needle Market recently published a Global Market research study with more than 100 industry...
Medical Products Market Share – Industry Analysis, Growth, Trends, Product, Top Key Players and Regional Forecast 2020-2026
12:47pm, Monday, 25'th May 2020
May 25, 2020 (Market Insight Reports) --
Selbyville, Delaware, Market Study Report LLC recently added a new title on 2020-2026 Global Medical Products Market...
Rice Hall James & Associates, Llc Buys Iovance Biotherapeutics Inc, Karyopharm Therapeutics ...
12:00am, Friday, 15'th May 2020Pacira BioSciences to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
11:30am, Wednesday, 13'th May 2020
PARSIPPANY, N.J., May 13, 2020 -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today reported that it will present at the 2020 RBC Capital Markets Global Healthcare Virtual.
Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q1 2020 Results - Earnings Call Transcript
09:07am, Monday, 11'th May 2020
Pacira BioSciences, Inc. (NASDAQ:PCRX) Q1 2020 Results Earnings Conference Call May 07, 2020, 08:30 AM ET Company Participants Susan Mesco - Head of Investor Re
Stifel Maintains Hold on Pacira BioSciences, Lowers Price Target to $48
05:41pm, Friday, 08'th May 2020SVB Leerink Maintains Outperform on Pacira BioSciences, Raises Price Target to $45
10:31am, Friday, 08'th May 2020Pacira's (PCRX) Q1 Earnings Top Estimates, Revenues Rise Y/Y
12:00am, Friday, 08'th May 2020Pacira BioSciences Q1 EPS $0.530 Beats $0.320 Estimate, Sales $105.684M Beat $102.970M Estimate
12:27pm, Thursday, 07'th May 2020Pacira BioSciences Q1 EPS $0.530 Beats $0.320 Estimate, Sales $105.700M Beat $102.970M Estimate
12:05pm, Thursday, 07'th May 2020Pacira BioSciences Reports First Quarter 2020 Financial Results and Business Update
12:00pm, Thursday, 07'th May 2020
-- Total revenues increased 16 percent over prior year first quarter ---- Conference call today at 8:30 a.m. ET -- PARSIPPANY, N.J., May 07, 2020 -- Pacira BioSciences, Inc..
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
NovaBay Pharmaceuticals Appoints Andrew D. Jones Chief Financial Officer
12:00am, Tuesday, 05'th May 2020
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the appointment of Andrew D. Jones as Chief Financial Officer and Treasurer, effective M
